医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
6期
84-84
,共1页
格列吡嗪%二甲双胍%2型糖尿病
格列吡嗪%二甲雙胍%2型糖尿病
격렬필진%이갑쌍고%2형당뇨병
Glipizide%Metformin%Type 2 diabetes
目的:观察格列吡嗪与二甲双胍合用治疗2型糖尿病患者,测量其空腹血糖,糖化血红蛋白,餐后2h血糖,肾功能,血脂,体重指数。方法把38例2型糖尿病患者随机分为两组,各19个病例。治疗组使用格列吡嗪和二甲双胍,对照组采用格列吡嗪,治疗3个月。观察两组治疗前后的空腹血糖,糖化血红蛋白,和餐后2h血糖,肾功能,血脂和体重指数的变化。结果两组治疗前后组,空腹血糖,餐后2h血糖,糖化血红蛋白下降。两组比较差异有统计学意义。结论格列吡嗪与二甲双胍合用可以更好的使空腹血糖,餐后2h血糖,糖化血红蛋白下降,并能引起血脂和体重指数下降。
目的:觀察格列吡嗪與二甲雙胍閤用治療2型糖尿病患者,測量其空腹血糖,糖化血紅蛋白,餐後2h血糖,腎功能,血脂,體重指數。方法把38例2型糖尿病患者隨機分為兩組,各19箇病例。治療組使用格列吡嗪和二甲雙胍,對照組採用格列吡嗪,治療3箇月。觀察兩組治療前後的空腹血糖,糖化血紅蛋白,和餐後2h血糖,腎功能,血脂和體重指數的變化。結果兩組治療前後組,空腹血糖,餐後2h血糖,糖化血紅蛋白下降。兩組比較差異有統計學意義。結論格列吡嗪與二甲雙胍閤用可以更好的使空腹血糖,餐後2h血糖,糖化血紅蛋白下降,併能引起血脂和體重指數下降。
목적:관찰격렬필진여이갑쌍고합용치료2형당뇨병환자,측량기공복혈당,당화혈홍단백,찬후2h혈당,신공능,혈지,체중지수。방법파38례2형당뇨병환자수궤분위량조,각19개병례。치료조사용격렬필진화이갑쌍고,대조조채용격렬필진,치료3개월。관찰량조치료전후적공복혈당,당화혈홍단백,화찬후2h혈당,신공능,혈지화체중지수적변화。결과량조치료전후조,공복혈당,찬후2h혈당,당화혈홍단백하강。량조비교차이유통계학의의。결론격렬필진여이갑쌍고합용가이경호적사공복혈당,찬후2h혈당,당화혈홍단백하강,병능인기혈지화체중지수하강。
Objective To observe glipizide in combination with metformin in patients with type 2 diabetes mel itus, fasting glucose, glycosylated hemoglobin, blood sugar 2 hours after meal, renal function, blood lipid, body mass index. Methods 38 patients with type 2 diabetes were randomly divided into two groups, each 19 cases. Treatment group using glipizide and metformin, control group adopts glipizide, treatment for 3 months. Observe two groups before and after treatment, the fasting glucose, glycosylated hemoglobin, and blood sugar 2 hours after meal, the change of renal function, blood lipid, and body mass index. Results In the two groups before and after treatment group, fasting blood glucose, blood sugar 2 hours after meal, glycosylated hemoglobin decreased. Conclusion Glipizide in combination with metformin can bet er control of fasting blood glucose, blood sugar 2 hours after meal, glycosylated hemoglobin, and can cause blood lipid and body mass index decline.